Parameter | Overall (n = 59) | Percentage | |
---|---|---|---|
Preoperative histopathology | T2 disease (muscle-invasive high-grade TCC), n (%) | 35 | 59.32 |
High-grade TCC not amenable to endoscopic/intravesical treatment, n (%) | 23 | 38.98 | |
High-grade TCC with squamous differentiation, n (%) | 7 | 11.86 | |
High-grade TCC with sarcomatoid differentiation, n (%) | 3 | 5.08 | |
Adenocarcinoma of bladder, n (%) | 2 | 3.38 | |
Pathological stage | pT1, n% | 7 | 11.86 |
pT2a, n (%) | 11 | 18.64 | |
pT2b, n (%) | 29 | 49.15 | |
pT3a, n(%) | 9 | 15.25 | |
pT3b, n(%) | 1 | 1.69 | |
pT4a, n(%) | 2 | 3.38 | |
pT4b, n (%) | 0(-) | 0 | |
Lymph nodal disease | pN0, n (%) | 42 | 71.18 |
pN1, n (%) | 2 | 3.38 | |
pN2, n (%) | 15 | 25.42 | |
pN3, n (%) | 0(-) | 0 | |
Overall Complications | Minor complications(Grade 1 + 2) | 9 | 15.25 |
Major complications (Grade 3 + 4 + 5) | 14 | 23.73 | |
GI-Related Complications | Post-operative ileus (POI) | 8 | 13.55 |
NG-tube placement | 5 | 8.47 | |
Total Parenteral Nutrition (TPN) | 3 | 5.08 | |
Nausea | 6 | 10.17 | |
Admission due to GI-related complications | 9 | 15.25 |